Researchers discover novel method for detecting MIRCERA Date: December 16, 2009 Source: Wiley-Blackwell Summary: Researchers have successfully developed a new electrophoretic method for detecting ...

Roche Pharmaceuticals quickly rejected claims that Roche planted secret molecule in Mircera which allowed for detection of the CERA class drug at the 2008 Tour de France. John Fahey, WADA ...

Roche Holding was barred by an appeals court from selling the anemia drug Mircera in the U.S. after a judge found that the Swiss company infringed patents held by Thousand Oaks-based Amgen Inc ...

But if Amgen succeeds in getting a permanent injunction against Mircera, Roche won't be able to sell the drug in the U.S. until at least 2012. That would be quite a setback. At least Roche won't ...

The U.S. District Court in Boston ruled yesterday that Amgen should get a permanent injunction against Roche's anemia med Mircera. This decision cements a previous jury's conclusion that Mircera ...

He was able to confirm that co-operation in the case of Mircera has enabled its detection by WADA-accredited laboratories. "Thanks to the co-operation of the manufacturer of this substance (Roche ...

Additional Mircera ® volume will provide Vifor Pharma with more flexibility to expand its US ESA business IN 2015 VIFOR PHARMA (FORMERLY A COMPANY OF GALENICA GROUP) ENTERED INTO AN EXCLUSIVE ...

ZURICH (MarketWatch) -- Roche Holding AG RHHBY plans to launch anemia drug Mircera immediately in the U.K. and Germany and is confident it will win U.S. approval for the drug later this year ...

New data for Roche’s anaemia drug Mircera confirm that the drug can raise haemoglobin levels in the blood with twice-monthly dosing, suggesting it will mount a strong challenge to current treatments ...

NUTLEY, N.J., Nov. 14 Roche announced today that the U.S. Food and Drug Administration (FDA) has approved MIRCERA (methoxy polyethylene glycol-epoetin beta) for the treatment of anemia associated ...

Roche Holding AG said Friday that the Food and Drug Administration has extended its review of the company's proposed drug, Mircera, for three months after the company submitted additional data for ...